Pharmaceutical News

RSS

Syrians in urgent need of life-saving medicines as fighting escalates, WHO warns

"Syrians are in urgent need of life-saving medicines following an escalation in fighting, which also threatens further food shortages, U.N. agencies warned on Tuesday," Agence France-Presse reports.

9 Aug 2012

Sirtuins help fight off obesity-linked diseases

A protein that slows aging in mice and other animals also protects against the ravages of a high-fat diet, including diabetes, according to a new MIT study.

9 Aug 2012

Theranostic imaging targets and tracks potent drug therapies to prostate cancer cells

Experimenting with human prostate cancer cells and mice, cancer imaging experts at Johns Hopkins say they have developed a method for finding and killing malignant cells while sparing healthy ones.

9 Aug 2012

Pathologist identifies HPV DNA fragments in post-mortem samples after Gardasil vaccination

According to Norma Erickson, President of SaneVax Inc., testimony provided for a coroner's inquest into the death of Jasmine Renata in New Zealand by Dr. Sin Hang Lee, a pathologist on the medical staff at Connecticut's Milford Hospital, revealed the discovery of HPV DNA fragments in post-mortem samples 6 months after Gardasil vaccination.

9 Aug 2012

Advocacy groups warn Trans-Pacific Partnership could affect access to low-cost medications, Bloomberg reports

Bloomberg Businessweek examines how ongoing trade negotiations related to the Trans-Pacific Partnership could affect access to quality low-cost medications, including antiretrovirals, in low- and middle-income countries. "Protecting the patents of drug makers ... as part of the Trans-Pacific Partnership has drawn criticism from groups such as Doctors Without Borders and Public Citizen," and "the proposed accord has also spurred calls from U.S. lawmakers for greater transparency about the negotiations," the news service writes.

9 Aug 2012

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Salix Pharmaceuticals, Ltd. and Alfa Wassermann S.p.A. today announced that they have entered into an exclusive agreement by which Salix has licensed rights in the United States and Canada to an extended intestinal release (EIR) formulation of rifaximin for gastrointestinal and respiratory indications, including Crohn's disease.

9 Aug 2012

Cardionovum to introduce PROLIMUS Biograde system in Europe

Cardionovum GmbH announced today that it expects to launch in Europe in Q4 2012 a next-generation Sirolimus-eluting coronary stent system—PROLIMUS Biograde—which is designed to optimize long-term patient results. Unlike many state-of-the-art DES that are currently being marketed, PROLIMUS Biograde provides multiple pro-healing product features to promote early re-endothelialization.

9 Aug 2012

APCER Pharma updates and enhances its website

APCER Pharma Solutions, Inc., the truly global provider of strategic and outsourced services for clinical safety, pharmacovigilance, medical affairs, and regulatory operations, announced today that it has updated and enhanced its website.

8 Aug 2012

Drug companies developing novel treatments for MDR-TB

With incentives to find new antibiotics signed into U.S. law last month, "multiple players are vying for the lead in the [multi-drug resistant tuberculosis (MDR-TB)] drug development niche," Nature Medicine reports.

8 Aug 2012

Malawi launches week-long campaign to test 250,000 people for HIV

"Malawi on Monday launched a week-long campaign to test 250,000 people for HIV in what health authorities called a crucial intervention in a country ravaged by AIDS," Agence France-Presse reports.

8 Aug 2012

RXMap helps increase medication adherence for older Americans

In a recent poll of Americans 65 years old and older, researches found that 51% take at least five different prescription drugs regularly. Fifty seven percent of those polled admit that they forget to take their medications.

8 Aug 2012

Global market value of Alzheimer's disease therapeutics could soar to $8 billion: GEN

The global market value of Alzheimer's disease therapeutics could soar to the $8 billion range once therapeutics are approved that actually change the course of the disease, reports Genetic Engineering & Biotechnology News (GEN).

8 Aug 2012

Statins and diabetes both increase cataract risk

Patients using cholesterol-lowering statin drugs may be at increased risk of developing age-related cataracts, according to a study - "Age-related Cataract Is Associated with Type 2 Diabetes and Statin Use", in the August issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

8 Aug 2012

Trans-Pacific Partnership trade agreement could restrict access to affordable, life-saving drugs

In this post in the PLoS "Speaking of Medicine" blog, Judit Rius Sanjuan, a lawyer from Barcelona, Spain, and the U.S. manager of the Access Campaign at Medecins Sans Frontieres (MSF), says the Trans-Pacific Partnership (TPP), a regional trade agreement that currently involves 11 countries but is slated for further expansion across the Asia-Pacific region, is threatening the prospects for an AIDS-free generation.

8 Aug 2012

Calcium and vitamin D supplements do not prevent bone loss in men with prostate cancer

Prescribing calcium and vitamin D supplements for men at risk of bone loss from hormonal treatment for prostate cancer seems like good medicine.

8 Aug 2012

Drug research “innovation crisis” is a myth

The widely touted “innovation crisis” in pharmaceutical research is a myth, argue experts in an article published on bmj.com today.

8 Aug 2012

GeneXpert TB test maker Cepheid signs deals with PEPFAR, USAID, others to provide lower-cost kits

Diagnostics company Cepheid on Monday signed deals with PEPFAR, USAID, UNITAID, and the Bill & Melinda Gates Foundation to immediately reduce the price of its Xpert MTB/RIF test kit for its GeneXpert tuberculosis (TB) diagnostic system in 145 countries, Reuters reports.

8 Aug 2012

Study compares mortality rates among RA patients treated with individual TNF inhibitors

New research confirms no significant difference in the rates of death among patients with rheumatoid arthritis (RA) who were exposed to one of several TNF inhibitors used to treat RA, adalimumab (Humira), etanercept (Enbrel), and infliximab (Remicade).

8 Aug 2012

Study reports new potential NOX inhibitor therapy for liver fibrosis

A study published in the online journal Hepatology reports a potential new NADPH oxidase (NOX) inhibitor therapy for liver fibrosis, a scarring process associated with chronic liver disease that can lead to loss of liver function.

8 Aug 2012

Depressive symptoms, suicidal thoughts more prevalent among former finasteride users

New research, to be published in the Journal of Clinical Psychiatry, finds that men who developed persistent sexual side effects while on finasteride (Propecia), a drug commonly used for male pattern hair loss, have a high prevalence of depressive symptoms and suicidal thoughts.

8 Aug 2012

Pharmaceutical News

Syrians in urgent need of life-saving medicines as fighting escalates, WHO warns

Sirtuins help fight off obesity-linked diseases

Theranostic imaging targets and tracks potent drug therapies to prostate cancer cells

Pathologist identifies HPV DNA fragments in post-mortem samples after Gardasil vaccination

Advocacy groups warn Trans-Pacific Partnership could affect access to low-cost medications, Bloomberg reports

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Cardionovum to introduce PROLIMUS Biograde system in Europe

APCER Pharma updates and enhances its website

Drug companies developing novel treatments for MDR-TB

Malawi launches week-long campaign to test 250,000 people for HIV

RXMap helps increase medication adherence for older Americans

Global market value of Alzheimer's disease therapeutics could soar to $8 billion: GEN

Statins and diabetes both increase cataract risk

Trans-Pacific Partnership trade agreement could restrict access to affordable, life-saving drugs

Calcium and vitamin D supplements do not prevent bone loss in men with prostate cancer

Drug research “innovation crisis” is a myth

GeneXpert TB test maker Cepheid signs deals with PEPFAR, USAID, others to provide lower-cost kits

Study compares mortality rates among RA patients treated with individual TNF inhibitors

Study reports new potential NOX inhibitor therapy for liver fibrosis

Depressive symptoms, suicidal thoughts more prevalent among former finasteride users

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News